Annual Congress: Hematologic Malignancies

2023 NCCN Hem Congress

Registration Open for the NCCN 2023 Annual Congress: Hematologic Malignancies™

Hilton San Francisco Union Square • San Francisco, California | Virtual attendance also available
Friday, September 22, 2023 – Saturday, September 23, 2023

Register now for great rates!
Learn More
Join us in San Francisco!
Register Now
Designed for the entire oncology team!
View Agenda

Hilton San Francisco Union Square

Continuing Education

Chaired by Andrew D. Zelenetz, MD, PhD, from Memorial Sloan Kettering Cancer Center, this program features presentations and interactive discussions highlighting the treatment options and supportive care for a variety of hematologic malignancies. This program is approved for AMA PRA Category 1 Credit™ and ABIM, ABPath, and ABMS MOC for physicians and is also certified for credit for nurses, pharmacists, and other oncology professionals.

Disease areas to be covered:

  • Acute Lymphocytic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
  • Chronic Myeloid Leukemia (CML)
  • Classical Hodgkin Lymphoma (CHL)
  • Mantle Cell Lymphoma (MCL)
  • Multiple Myeloma (MM)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Waldenström Macroglobulinemia (WM)

Additional topics:

  • Anticoagulation and Antithrombotic Therapy
  • Bispecific T-cell Engagers
  • BTK Inhibitors
  • Graft-Versus-Host Disease
  • Toxicities in CAR T-cell Therapy
  • Updates in WHO/ICC Classification System

For CE program supporter opportunities, contact Lisa Perfidio, Senior Manager, CE Supporter Outreach.

Exhibition Hall

View Exhibitor Prospectus


For exhibitor opportunities, contact Jennifer Tredwell, Vice President, Marketing and Communications